Opyl (ASX: OPL)  are a Melbourne based company with client service and development teams in both Australia and the US.

Opyl provides biopharma and health organisations access to emerging AI-assisted technologies and professional guidance to understand and improve healthcare design, development and delivery.

KEY PEOPLE

Dr Julian Chick, Chairman

read more

Marat Basyrov, Non Executive Director

read more

Michelle Gallaher, Chief Executive Officer

read more

Damon Rasheed, Non Executive Director

read more

David Iilja, Company Secretary

read more

RELATED STOCKHEAD STORIES